The Soviet Union’s Invisible Weapons of Mass Destruction: Biopreparat's Covert Biological Warfare Programme
Autor Anthony Rimmingtonen Limba Engleză Paperback – 14 oct 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 713.13 lei 43-57 zile | |
Springer International Publishing – 14 oct 2022 | 713.13 lei 43-57 zile | |
Hardback (1) | 718.34 lei 43-57 zile | |
Springer International Publishing – 13 oct 2021 | 718.34 lei 43-57 zile |
Preț: 713.13 lei
Preț vechi: 869.67 lei
-18% Nou
Puncte Express: 1070
Preț estimativ în valută:
136.52€ • 140.40$ • 113.26£
136.52€ • 140.40$ • 113.26£
Carte tipărită la comandă
Livrare economică 17 februarie-03 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030828844
ISBN-10: 3030828840
Pagini: 269
Ilustrații: XV, 269 p. 20 illus.
Dimensiuni: 148 x 210 mm
Greutate: 0.38 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Palgrave Macmillan
Locul publicării:Cham, Switzerland
ISBN-10: 3030828840
Pagini: 269
Ilustrații: XV, 269 p. 20 illus.
Dimensiuni: 148 x 210 mm
Greutate: 0.38 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Palgrave Macmillan
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1: Introduction.- Chapter 2: The Secret History: Khrushchev’s Creation of Soviet Reserve Biological Warfare Mobilization Facilities within Civil Production Plants in the 1950s and 1960s.- Chapter 3: Glavmikrobioprom and the Emergence of the Soviet Microbiological Industry.- Chapter 4: Genesis: The Creation of Biopreparat.- Chapter 5: Anthrax on the Kazakh Steppe: Biopreparat’s Network of Experimental-Industrial Bases.- Chapter 6: The Creation of Biopreparat’s Scientific Base: The R&D Complexes at Obolensk, Kol’tsovo and Leningrad.- Chapter 7: A Roadmap to the Future? The Emergence of Biopreparat as a Major Civil Biopharmaceutical Player.- Chapter 8: A Brave New World: Building Capitalism in the New Russia and the Struggle for Control of Biopreparat.- Chapter 9: Conclusion.
Notă biografică
Anthony Rimmington is a former Senior Research Fellow at Birmingham University’s Centre for Russian, European and Eurasian Studies, UK. He has published widely on the civil life sciences sector in the post-Soviet states and on the USSR’s offensive biological warfare programme, including The Soviet Union’s Agricultural Biowarfare Programme: Ploughshares to Swords (Palgrave, 2021).
Textul de pe ultima copertă
This book focuses on Biopreparat, the Soviet agency created in 1974, which spearheaded the largest and most sophisticated biological warfare programme the world has ever seen. At its height, Biopreparat employed more than 30,000 personnel and incorporated an enormous network embracing military-focused research institutes, design centres, biowarfare pilot facilities and dual-use production plants. The secret network pursued major offensive R&D programmes, which sought to use genetic engineering techniques to create microbial strains resistant to antibiotics and with wholly new and unexpected pathogenic properties. During the mid-1980s, Biopreparat increased in size and political importance and also emerged as a major civil biopharmaceutical player in the USSR. In the wake of the collapse of the Soviet Union in 1991, an acute struggle for control of Biopreparat’s most valuable assets took place and the network was eventually broken-up and control of its facilities transferred to a myriad of state agencies and private companies.
Anthony Rimmington is a former Senior Research Fellow at Birmingham University’s Centre for Russian, European and Eurasian Studies, UK. He has published widely on the civil life sciences sector in the post-Soviet states and on the USSR’s offensive biological warfare programme, including The Soviet Union’s Agricultural Biowarfare Programme: Ploughshares to Swords (Palgrave, 2021).
Caracteristici
Focuses on the history of Biopreparat, an important component of the Soviet offensive biological warfare programme Draws upon official documents relating to Biopreparat within the Russian state archives Also includes interviews with UK bioscience companies which interacted with Biopreparat